Concepedia
Statistics
Publications
1
Citations
38
H-Index
Active since
2014
Affiliations
Heron Therapeutics (United States)(Current)
Mark Gelder is an author at Heron Therapeutics (United States).
Publications per year
2014–2014
Biochronomer™ technology and the development of APF530, a sustained release formulation of granisetron
Thomas Ottoboni, Mark Gelder, Erin O’Boyle · Journal of Experimental Pharmacology · 2014 · 38 citations · Full text
1–1 of 1